02/05/2016

Report no. 13/2016

Amendment to a significant contract by the subsidiary of the Issuer-Regionalne Centrum Zdrowia Sp. z o.o. in Lubin

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19th February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A. informs that on 5th February 2016 the Company received information that the value of the contracts signed by the subsidiary Regionalne Centrum Zdrowia Sp. z o. o. in Lubin and the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) has changed. The said contracts referred to healthcare services in the scope of nursing and care services in terms of the long-term care as well as primary healthcare for the period 1st January to 31st December 2015. Healthcare services specified hereinabove are provided by the Hospital administered by the subsidiary of EMC Instytut Medyczny S.A. - Regionalne Centrum Zdrowia Sp. z o. o. in Lubin.

The Issuer informed about the contracts concluded by Regionalne Centrum Zdrowia Sp. z o.o. concerning services rendered in 2015 in its current reports nos. 7/2015 of 16.01.2015, 12/2015 of 30.01.2015, 48/2015 of 10.06.2015, 49/2015 of 16.06.2015, 54/2015 of 8.07.2015, 58/2015 of 7.08.2015, 60/2015 of 21.08.2015, 63/2015 of 03.09.2015, 71/2015 of 16.10.2015, 83/2015 of 30.11.2015, 89/2015 of 07.12.2015, 1/2016 of 4.01.2016 and 9/2016 of 4.02.2016. As a result of signing the said annexes to the contracts with the National Health Fund regarding healthcare services provided and the payment for primary health care services in the period 1st January to 31st December 2015, the value of the contract with highest value has not changed and it currently amounts to PLN 50 325,123.00. The total maximum Fund Branch liability towards the subsidiary of the Issuer currently amounts to PLN 58, 933,338.07 ( an increase by PLN 137,745.72) for the period 1st January to 31st December 2015. A criterion for a contract to be considered significant: The value of contracts exceeds 10% of the Issuer’s equity capital. Raport nr 12/2016